
Intambwe nini ya kanseri y'ibihaha ntoya (ES-SCLC) itanga ibibazo bidasanzwe. Ubuvuzi busanzwe bukubiyemo imiti ya chimiotherapie hamwe na immunotherapie, akenshi hamwe no kuvura imirasire kugirango bikemure ibimenyetso. Ubushakashatsi burimo gukorwa bushakisha uburyo bushya bwo kuvura no gufata ingamba zo kunoza ibyagezweho n’ubuzima bwiza ku barwayi barwaye ES-SCLC. Gusobanukirwa Icyiciro kinini Kanseri y'ibihaha ntoyaIcyiciro kinini kanseri y'ibihaha ntoya (ES-SCLC) isuzumwa iyo kanseri imaze gukwirakwira hejuru y'ibihaha hamwe na lymph node. Ibi bivuze ko yapimye mubindi bice byumubiri, nkibindi bihaha, lymph node ya kure, amagufa, umwijima, cyangwa ubwonko. Kanseri y'ibihaha ntoya (SCLC) ni ubwoko bukabije bwa kanseri y'ibihaha ikura kandi ikwirakwira vuba. Ku cyiciro kinini, ubuvuzi bwibanda ku kurwanya kanseri no kuzamura imibereho. Gusuzuma no GupimaGusuzuma neza no kuyitegura ni ngombwa mu kumenya ibikwiye icyiciro kinini kuvura kanseri y'ibihaha gahunda. Uburyo bwo kwisuzumisha bushobora kubamo: Ikizamini cyumubiri namateka yubuvuzi Ibizamini byerekana amashusho: Isanduku ya X-ray, CT scan, PET scan, MRI Biopsy: Kwemeza ko hariho kanseri ntoya yibihaha ya kanseri yibihaha Amagufa: Kugenzura kanseri ikwirakwira kumagufwaSandard uburyo bwo kuvura ibyiciro byinshi SCLCUburyo busanzwe bwo kuvura icyiciro kinini kanseri ntoya yibihaha harimo chimiotherapie, immunotherapy, hamwe nubuvuzi bwimirasire. Ubu buvuzi bukoreshwa kenshi muguhuza ibisubizo byiza bishoboka.ChemotherapieChemotherapie nubuvuzi bwibanze kuri ES-SCLC. Harimo gukoresha ibiyobyabwenge kugirango bice selile kanseri mumubiri. Uburyo rusange bwa chimiotherapie burimo: Ibiyobyabwenge bya Etoposide na platine (cisplatine cyangwa karboplatine) Irinotecan hamwe n’ibiyobyabwenge bishingiye kuri platineChemotherapie ikunze gutangwa mu bihe, hamwe n’ibihe byo kuvura bikurikirwa n’ibiruhuko kugira ngo umubiri ukire. Ingaruka mbi za chimiotherapie zirashobora kubamo isesemi, kuruka, umunaniro, guta umusatsi, hamwe no kongera ibyago byo kwandura.ImmunotherapyImmunotherapy nuburyo bushya bwo kuvura bufasha sisitemu yumubiri yumubiri kurwanya kanseri. Immune igenzura ibiyobora, nka atezolizumab na durvalumab, ikoreshwa kenshi hamwe na chimiotherapie ya icyiciro kinini kuvura kanseri y'ibihaha. Iyi miti ikora mu guhagarika poroteyine ku ngirabuzimafatizo za kanseri cyangwa ingirabuzimafatizo zirinda umubiri kwirinda indwara ya kanseri. Muri IMpower133, OS yo hagati yari amezi 12.3 hamwe na atezolizumab / chimiotherapie n'amezi 10.3 hamwe na chimiotherapie (HR, 0.70; 95% CI, 0.54–0.91; P = 0.0069)Inkomoko: Umuyoboro wa KanseriImirasire ivura Imirasire ikoresha imirasire yingufu nyinshi kugirango yice kanseri. Irashobora gukoreshwa: Kuvura ibibyimba mu bihaha cyangwa mu bindi bice byumubiri Kuruhura ibimenyetso nkububabare cyangwa ingorane zo guhumeka Kurinda cyangwa kuvura metastase yubwonkoProphylactic cranial irradiation (PCI) irashobora gusabwa gukumira ikwirakwizwa rya kanseri mubwonko. Ingaruka mbi zo kuvura imirasire zirashobora kuba zirimo umunaniro, kurakara kuruhu, hamwe no kumira bunguri.Ibindi bitekerezo byo kuvuraIbizamini bya Clinical Ibigeragezo bya kliniki ni ubushakashatsi bwubushakashatsi bukora ubushakashatsi ku buvuzi bushya nubuvuzi. Abarwayi hamwe icyiciro kinini kanseri ntoya yibihaha irashobora kwemererwa kwitabira ibizamini byo kwa muganga isuzuma imiti mishya, guhuza imiti, cyangwa ubundi buryo bushya. Ubuvuzi bwa Palliative CarePalliative care bwibanda ku kugabanya ibimenyetso no kuzamura imibereho y’abarwayi bafite uburwayi bukomeye. Irashobora gutangwa hamwe nubundi buvuzi kandi irashobora gufasha gucunga ububabare, umunaniro, guhumeka neza, nibindi bimenyetso bifitanye isano na ES-SCLC. Itsinda ry'impuguke kuri Shandong Baofa Ikigo Cyubushakashatsi Kanseri ishimangira kwinjiza ubuvuzi bwa palliative muri gahunda yo kuvura kuva mbere. Inkunga yimirireGukomeza imirire myiza nibyingenzi kubarwayi barimo kwivuza icyiciro kinini kanseri ntoya yibihaha. Indyo yuzuye irashobora gufasha kuzamura urwego rwingufu, gushyigikira sisitemu yumubiri, no gucunga ingaruka zokuvura. Umuganga w’imirire yiyandikishije arashobora gutanga ubuyobozi ku ngeso nziza zo kurya kandi akanasaba inyongeramusaruro nibikenewe.Gutegura no GukurikiranaIbimenyesha abarwayi bafite icyiciro kinini kanseri ntoya yibihaha muri rusange ni umukene, ariko kuvura birashobora gufasha kurwanya kanseri, kuzamura imibereho, no kuramba. Guhora mukurikirana gahunda hamwe nitsinda rya oncology nibyingenzi mugukurikirana ibisubirwamo, gucunga ingaruka, no gutanga inkunga ihoraho. Uwiteka Shandong Baofa Ikigo Cyubushakashatsi Kanseri yitangiye kunoza imenyekanisha no gukurikirana abarwayi.Kubaho hamwe na Stage Nini ya Kanseri Ntoya y'ibihaha Kanseri Kubana hamwe icyiciro kinini kanseri ntoya yibihaha birashobora kuba ingorabahizi, haba kumubiri no mumarangamutima. Ni ngombwa kugira gahunda ikomeye yo gushyigikira, harimo umuryango, inshuti, ninzobere mu buzima. Amatsinda atera inkunga hamwe na serivisi zubujyanama birashobora kandi gutanga ubufasha bwingirakamaro mugukemura ibibazo bya kanseri. Gucunga ibimenyetso Ibimenyetso Gukoresha ibimenyetso nibintu byingenzi byo kubana na ES-SCLC. Imiti, imiti, hamwe nimpinduka zubuzima birashobora gufasha kugabanya ububabare, umunaniro, guhumeka neza, nibindi bimenyetso. Itumanaho rihoraho hamwe nitsinda ryita ku buzima ni ngombwa kugira ngo ibimenyetso bikemurwe neza.Inkunga y’amarangamutimaGukemura indwara ya kanseri birashobora kuba birenze amarangamutima. Ni ngombwa gushaka inkunga y'amarangamutima kubantu ukunda, amatsinda atera inkunga, cyangwa inzobere mu buzima bwo mu mutwe. Kuvuga ibyiyumvo n'impungenge birashobora gufasha kugabanya imihangayiko no kuzamura imibereho myiza muri rusange. Gutanga imiti hamwe nubushakashatsiUbushakashatsi muburyo bushya bwo kuvura icyiciro kinini kanseri ntoya yibihaha birakomeje. Ubuvuzi bugaragara, nk'ubuvuzi bugamije hamwe n'ubudahangarwa bw'udushya, byerekana amasezerano mu kuzamura umusaruro w'abarwayi bafite ES-SCLC. Igeragezwa rya Clinical ni ngombwa mu guteza imbere ubushakashatsi bwa kanseri no kuzana imiti mishya ku barwayi.Amakuru yatanzwe muri iki gitabo ni ay'ubumenyi rusange n'intego zo gutanga amakuru gusa, kandi ntabwo ari inama z'ubuvuzi. Ni ngombwa kugisha inama inzobere mu by'ubuzima zibishoboye kubibazo byose byubuzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa kwivuza.